Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Generation Bio to Present at the Evercore ISI Healthcare Conference

Generation Bio
Posted on: 19 Nov 18

Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, today announced that the company will present at the Evercore ISI Healthcare Conference in Boston, MA. President and Chief Executive Officer Geoff McDonough will provide an overview of the company on Wednesday, November 28, 2018 at 9:50 a.m. EST.

To access a live webcast and subsequent archived recording of the presentation, please visit the “News” section on the Generation Bio website at

About Generation Bio
Generation Bio is a biotechnology company developing a breakthrough class of genetic medicines to enable a new generation of people unaffected by inherited disease. The company’s therapies are based on its proprietary ceDNA technology, which delivers durable, high levels of gene expression and can be re-dosed to titrate to effect and to sustain impact over a lifetime. Generation Bio was founded and launched by Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit or follow @lifetimegenetx.

View source version on

Business Wire

Last updated on: 19/11/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.